| 产品详情 |
| Edit |   |
|---|
| Product Name | Lenalidomide |
|---|
| Description | MW: 259.26. Clinically, lenalidomide has proven to be effective in the treatment of multiple myeloma and other B cell diseases. It has the ability to selectively bind and ubiquitinate two lymphoid transcription factors, IKZF1 and IKZF2, via the CRBN-CRL4 ubiquitin ligase. This ultimately leads to the degradation of IKZF1 and IKZF2, which are both essential in myeloma cell survival. |
|---|
| Size | 10 mg, 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione |
|---|
| Gene, Accession, CAS # | CAS: 191732-72-6 |
|---|
| Catalog # | abx076543 |
|---|
| Price | |
|---|
| Order / More Info | Lenalidomide from ABBEXA |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|